We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Submission dates and how the submissions using the EC decision reliance procedure work.
Submissions related to human medicines need to be submitted directly to the MHRA.
How to submit an application, data package and responses for proposed or existing marketing authorisations.
Webinars for pharmaceutical companies, clinical trial sponsors, e-cigarette producers and brokers of medicinal products
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Guide to submitting research applications to the Administration of Radioactive Substances Advisory Committee (ARSAC).
Find out how to submit your research to Athena, Dstl's central repository of MOD-sponsored scientific and technical research reports.
5 quick tips on submitiing your paper for review
A platform for the online transfer of information and documentation.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
A guide for principal designers, principal contractors and accountable persons to report incidents or risks of structural failure, or the spread of fire to the Building Safety Regulator.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
How to submit a proposal to the Defence and Security Accelerator
Instructions on how members of the public can submit their submissions to support the work of the team of experts leading the review.
Send files, pay fees and track cases in the High Court and the upper tribunals.
You should follow the standard file process outlined below when submitting work for online and paper billing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).